PURPOSE: Moyamoya disease, a rare cause of pediatric stroke, is a cerebrovascular occlusive disorder resulting from progressive stenosis of the distal intracranial carotid arteries and their proximal branches. In response to brain ischemia, there is the development of basal collateral vessels, which give rise to the characteristic angiographic appearance of moyamoya. If left untreated, the disease can result in overwhelming permanent neurological and cognitive deficits. METHODS: Whereas moyamoya disease refers to the idiopathic form, moyamoya syndrome refers to the condition in which children with moyamoya also have a recognized clinical disorder. As opposed to adults who typically present in the setting of intracranial hemorrhage, the classic pediatric presentation is recurrent transient ischemic attacks and/or completed ischemic strokes. RESULTS: Surgical revascularization, including direct and indirect techniques, remains the mainstay of treatment, and has been shown to improve long-term outcome in children with moyamoya. CONCLUSION: The authors discuss the diagnosis and treatment of moyamoya disease in the pediatric population.
PURPOSE:Moyamoya disease, a rare cause of pediatric stroke, is a cerebrovascular occlusive disorder resulting from progressive stenosis of the distal intracranial carotid arteries and their proximal branches. In response to brain ischemia, there is the development of basal collateral vessels, which give rise to the characteristic angiographic appearance of moyamoya. If left untreated, the disease can result in overwhelming permanent neurological and cognitive deficits. METHODS: Whereas moyamoya disease refers to the idiopathic form, moyamoya syndrome refers to the condition in which children with moyamoya also have a recognized clinical disorder. As opposed to adults who typically present in the setting of intracranial hemorrhage, the classic pediatric presentation is recurrent transient ischemic attacks and/or completed ischemic strokes. RESULTS: Surgical revascularization, including direct and indirect techniques, remains the mainstay of treatment, and has been shown to improve long-term outcome in children with moyamoya. CONCLUSION: The authors discuss the diagnosis and treatment of moyamoya disease in the pediatric population.
Authors: Y Numaguchi; C F Gonzalez; P C Davis; A Monajati; E Afshani; J Chang; C L Sutton; R R Lee; D K Shibata Journal: Clin Neurol Neurosurg Date: 1997-10 Impact factor: 1.876
Authors: K Wakai; A Tamakoshi; K Ikezaki; M Fukui; T Kawamura; R Aoki; M Kojima; Y Lin; Y Ohno Journal: Clin Neurol Neurosurg Date: 1997-10 Impact factor: 1.876
Authors: Raphael Guzman; Marco Lee; Achal Achrol; Teresa Bell-Stephens; Michael Kelly; Huy M Do; Michael P Marks; Gary K Steinberg Journal: J Neurosurg Date: 2009-11 Impact factor: 5.115
Authors: Giuseppe Esposito; Annick Kronenburg; Jorn Fierstra; Kees P J Braun; Catharina J M Klijn; Albert van der Zwan; Luca Regli Journal: Childs Nerv Syst Date: 2015-02-27 Impact factor: 1.475
Authors: Jennifer K Lee; Monica Williams; Jacky M Jennings; Jessica L Jamrogowicz; Abby C Larson; Lori C Jordan; Eugenie S Heitmiller; Charles W Hogue; Edward S Ahn Journal: Paediatr Anaesth Date: 2013-03-18 Impact factor: 2.556
Authors: Ignazio G Vetrano; Anna Bersano; Isabella Canavero; Francesco Restelli; Gabriella Raccuia; Elisa F Ciceri; Giuseppe Faragò; Andrea Gioppo; Morgan Broggi; Marco Schiariti; Laura Gatti; Paolo Ferroli; Francesco Acerbi Journal: J Clin Med Date: 2021-05-25 Impact factor: 4.241